Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 3
1996 3
1997 2
1999 4
2001 3
2002 1
2003 2
2004 3
2005 10
2006 5
2007 8
2008 8
2009 7
2010 7
2011 11
2012 9
2013 5
2014 9
2015 12
2016 17
2017 10
2018 6
2019 10
2020 14
2021 16
2022 11
2023 12
2024 13
2025 11
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. Among authors: oridate n. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.
Oridate N, Takahashi S, Tanaka K, Shimizu Y, Fujimoto Y, Matsumoto K, Yokota T, Yamazaki T, Takahashi M, Ueda T, Hanai N, Yamaguchi H, Hara H, Yoshizaki T, Yasumatsu R, Nakayama M, Shiga K, Fujii T, Mitsugi K, Takahashi K, Nohata N, Gumuscu B, Lerman N, Tahara M. Oridate N, et al. Int J Clin Oncol. 2024 Dec;29(12):1825-1839. doi: 10.1007/s10147-024-02632-x. Epub 2024 Oct 9. Int J Clin Oncol. 2024. PMID: 39382718 Free PMC article. Clinical Trial.
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.
Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T, Mitani H, Iwae S, Fujimoto Y, Onozawa Y, Hanai N, Ogawa T, Hara H, Monden N, Shimura E, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Ota I, Shiga K, Sugasawa M, Asakage T, Saito Y, Murono S, Nishimura Y, Nakamura K, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Kiyota N, et al. Among authors: oridate n. J Clin Oncol. 2022 Jun 20;40(18):1980-1990. doi: 10.1200/JCO.21.01293. Epub 2022 Mar 1. J Clin Oncol. 2022. PMID: 35230884 Free PMC article. Clinical Trial.
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
Nishimura G, Taguchi T, Takahashi M, Shiono O, Komatsu M, Sano D, Yabuki K, Arai Y, Takahashi H, Hata M, Oridate N. Nishimura G, et al. Among authors: oridate n. Cancer Chemother Pharmacol. 2016 Jun;77(6):1315-9. doi: 10.1007/s00280-016-3052-4. Epub 2016 May 6. Cancer Chemother Pharmacol. 2016. PMID: 27154176 Clinical Trial.
Human papillomavirus-driven head and neck cancers in Japan during 2008-2009 and 2018-2019: The BROADEN study.
Nibu KI, Oridate N, Saito Y, Roset M, Forés Maresma M, Cuadras D, Morais E, Roberts C, Chen YT, Spitzer J, Sato K, Saito I, Tazaki I, Clavero O, Schroeder L, Alemany L, Mehanna H, Mirghani H, Giuliano AR, Pavón MA, Waterboer T. Nibu KI, et al. Among authors: oridate n. Cancer Sci. 2024 Aug;115(8):2808-2818. doi: 10.1111/cas.16230. Epub 2024 Jun 7. Cancer Sci. 2024. PMID: 38847353 Free PMC article.
[Laryngopharyngeal reflux].
Takeda H, Oridate N, Shimizu Y, Kato M, Asaka M, Fukuda S, Yamamoto J. Takeda H, et al. Among authors: oridate n. Nihon Rinsho. 2007 May;65(5):921-5. Nihon Rinsho. 2007. PMID: 17511234 Review. Japanese.
Transoral robotic surgery (TORS) in Japan: procedures, advantages and current status.
Sano D, Tateya I, Hori R, Ueda T, Mori T, Maruo T, Tsukahara K, Oridate N; Committee for Transoral Robotic Surgery, Japan Society for Head and Neck Surgery. Sano D, et al. Among authors: oridate n. Jpn J Clin Oncol. 2024 Mar 9;54(3):248-253. doi: 10.1093/jjco/hyad168. Jpn J Clin Oncol. 2024. PMID: 38061912 Free article. Review.
213 results